Body Mass Index and von Hippel-Lindau Gene Mutations in Clear-cell Renal Cancer: Results of the Netherlands Cohort Study on Diet and Cancer

Annals of Epidemiology

Volumn 20, Issue 5, 2010, Pages 401-404

  Smits, Kim M ^a   Schouten, Leo J ^a   Hudak, Eszter ^a   Verhage, Bas ^a   van Dijk, Boukje A C ^a   Hulsbergen van de Kaa, Christina A ^b   Goldbohm, R Alexandra ^c   Oosterwijk, Egbert ^b   van den Brandt, Piet A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TNO   (Netherlands)

Author keywords

Body Mass Index; Clear cell Renal Cancer; VHL Mutations

Indexed keywords

VON HIPPEL LINDAU PROTEIN;

ADULT; AGE; ARTICLE; BODY MASS; CANCER RISK; CLEAR CELL CARCINOMA; COHORT ANALYSIS; CONTROLLED STUDY; DIET; FEMALE; GENE MUTATION; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; WEIGHT GAIN; WILD TYPE;

ADULT; BODY MASS INDEX; CARCINOMA, RENAL CELL; COHORT STUDIES; CONFIDENCE INTERVALS; DIET; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NETHERLANDS; NUTRITIONAL STATUS; RISK FACTORS; VON HIPPEL-LINDAU DISEASE; YOUNG ADULT;

EID: 77951279256     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2010.01.010     Document Type: Article

References (22)

1. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007, 18:381-392. Epub Feb 7.
2. Banks R.E., Tirukonda P., Taylor C., Hornigold N., Astuti D., Cohen D., et al. Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer. Cancer Res 2006, 66:2000-2011.
3. Bergstrom A., Pisani P., Tenet V., Wolk A., Adami H.O. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001, 91:421-430.
4. van Dijk B.A., Schouten L.J., Kiemeney L.A., Goldbohm R.A., van den Brandt P.A. Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort Study. Am J Epidemiol 2004, 160:1159-1167.
5. Peters I., Vaske B., Albrecht K., Kuczyk M.A., Jonas U., Serth J. Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue. Cancer Epidemiol Biomarkers Prev 2007, 16:2526-2532.
6. Richards F.M. Molecular pathology of von Hippel-Lindau disease and the VHL tumour suppressor gene. Expert Rev Mol Med 2001 Mar 19, 2001:1-27.
7. Kaelin W.G. The von Hippel-Lindau tumor suppressor gene and kidney cancer. Clin Cancer Res 2004, 10(18 Pt 2):6290S-6295S.
8. van Dijk B.A., Schouten L.J., Oosterwijk E., Hulsbergen-van de Kaa C.A., Kiemeney L.A., Goldbohm R.A., et al. Cigarette smoking, von Hippel-Lindau gene mutations and sporadic renal cell carcinoma. Br J Cancer 2006, 95:374-377.
9. Gnarra J.R., Duan D.R., Weng Y., Humphrey J.S., Chen D.Y., Lee S., et al. Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim Biophys Acta 1996, 1242:201-210.
10. Yu H., Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000, 92:1472-1489.
11. Vainio H., Kaaks R., Bianchini F. Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev 2002, 11(Suppl. 2):S94-S100.
12. Datta K., Nambudripad R., Pal S., Zhou M., Cohen H.T., Mukhopadhyay D. Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer. J Biol Chem 2000, 275:20700-20706.
13. Gago-Dominguez M., Castelao J.E., Yuan J.M., Ross R.K., Yu M.C. Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control 2002, 13:287-293.
14. Gago-Dominguez M., Castelao J.E. Lipid peroxidation and renal cell carcinoma: further supportive evidence and new mechanistic insights. Free Radic Biol Med 2006, 40:721-733.
15. van den Brandt P.A., Goldbohm R.A., van't Veer P., Volovics A., Hermus R.J., Sturmans F. A large-scale prospective cohort study on diet and cancer in The Netherlands. J Clin Epidemiol 1990, 43:285-295.
16. van Houwelingen K.P., van Dijk B.A., Hulsbergen-van de Kaa C.A., Schouten L.J., Gorissen H.J., Schalken J.A., et al. Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study. BMC Cancer 2005, 5:57.
17. Schouten L.J., van Dijk B.A., Oosterwijk E., Hulsbergen-van de Kaa C.A., Kiemeney L.A., Goldbohm R.A., et al. Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study. J Hypertens 2005, 23:1997-2004.
18. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000, 894(i-xii):1-253.
19. Wacholder S., Gail M., Pee D., Brookmeyer R. Alternative variance and efficiency calculations for the case-cohort design. Biometrika 1989, 76:117-123.
20. de Vogel S., Bongaerts B.W., Wouters K.A., Kester A.D., Schouten L.J., de Goeij A.F., et al. Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer. Carcinogenesis 2008, 29:1765-1773.
21. Kuczmarski M.F., Kuczmarski R.J., Najjar M. Effects of age on validity of self-reported height, weight, and body mass index: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Diet Assoc 2001, 101:28-34. quiz 35-36.
22. Niedhammer I., Bugel I., Bonenfant S., Goldberg M., Leclerc A. Validity of self-reported weight and height in the French GAZEL cohort. Int J Obes Relat Metab Disord 2000, 24:1111-1118.